Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides
Recruiting
Early Phase 1
Interventional Study
Plantar Fascitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 84 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Plantar fascitiis Aged between 18 and 80 years old
Exclusion Criteria:
* Previous surgery of the foot
* Contraindications to ESWT
Contacts